Related Articles
Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer Corrigendum in /10.3892/mco.2021.2247
Carbohydrate antigen 19‑9 as a prognostic biomarker in pancreatic neuroendocrine tumors
Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
Alteration of the serum myostatin level following L‑carnitine treatment in patients with chronic liver disease: A pilot study
Clinical usefulness of serum and immunohistochemical markers in patients with stage Ia and Ic ovarian cancer